Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2025-10-07 00:00:00 ET · period of report 2025-10-03 · accession 0001966716-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-07 | 2025-10-03 | STOK | Allan Jonathan | GC, CORP SEC | M - OptEx | $9.15 | +10.0K | 21.8K | +85% | +$91.5K |
| D | 2025-10-07 | 2025-10-03 | STOK | Allan Jonathan | GC, CORP SEC | S - Sale+OE | $25.07 | -10.0K | 11.8K | -46% | -$250.7K |
| D | 2025-10-07 | 2025-10-03 | STOK | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | -10.0K | 34.8K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-03 | M | A | 10,000 | $9.15 | 21,831 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-03 | S | D | 10,000 | $25.07 | 11,831 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-10-03 | M | D | 10,000 | $0.00 | 34,800 | D | $9.15 · — to 2033-03-14 | 10,000 Common Stock | (F3) The option vested or vests as to 1/48th of the total award on April 15, 2023, with an additional 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. |